Zubair A Qureshi
Overview
Explore the profile of Zubair A Qureshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
743
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qureshi Z, Hittle L, OHara J, Rivera J, Syed A, Shields R, et al.
Clin Infect Dis
. 2015 Jan;
60(9):1295-303.
PMID: 25632010
Background: With an increase in the use of colistin methansulfonate (CMS) to treat carbapenem-resistant Acinetobacter baumannii infections, colistin resistance is emerging. Methods: Patients with infection or colonization due to colistin-resistant...
2.
Qureshi Z, Syed A, Doi Y
Antimicrob Agents Chemother
. 2014 Apr;
58(6):3437-40.
PMID: 24709258
Ertapenem is increasingly utilized in outpatient parenteral antimicrobial therapy (OPAT), but data regarding the efficacy and safety of long-term ertapenem therapy have been limited. We conducted a retrospective cohort study...
3.
Qureshi Z, Doi Y
Expert Rev Anti Infect Ther
. 2014 Apr;
12(5):597-609.
PMID: 24694052
Escherichia coli ST131 has emerged as a global epidemic, multidrug-resistant clone of E. coli causing extra-intestinal infections. It is now highly prevalent among fluoroquinolone-resistant and CTX-M ESBL-producing E. coli isolates...
4.
Qureshi Z, Syed A, Clarke L, Doi Y, Shields R
Antimicrob Agents Chemother
. 2014 Mar;
58(6):3100-4.
PMID: 24637691
Carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria is a frequently encountered clinical condition, but its clinical impact is unknown. We conducted a retrospective cohort study to define the epidemiology and outcomes for...
5.
Kim Y, Qureshi Z, Adams-Haduch J, Park Y, Shutt K, Doi Y
Clin Infect Dis
. 2012 Apr;
55(2):224-31.
PMID: 22491340
Background: Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae has become endemic in many US hospitals. On the other hand, KPC-producing Escherichia coli remains rare. Methods: We studied infection or colonization due...
6.
Qureshi Z, Paterson D, Potoski B, Kilayko M, Sandovsky G, Sordillo E, et al.
Antimicrob Agents Chemother
. 2012 Jan;
56(4):2108-13.
PMID: 22252816
Klebsiella pneumoniae producing Klebsiella pneumoniae carbapenemase (KPC) has been associated with serious infections and high mortality. The optimal antimicrobial therapy for infection due to KPC-producing K. pneumoniae is not well...
7.
Qureshi Z, Kwak E, Nguyen M, Silveira F
Clin Transplant
. 2011 Sep;
26(1):E17-23.
PMID: 21955216
The dematiaceous mold Ochroconis gallopava is increasingly recognized as a human pathogen. Infection is almost always associated with immunosuppression. We describe a case with a unique presentation in a kidney...
8.
Waltner-Toews R, Paterson D, Qureshi Z, Sidjabat H, Adams-Haduch J, Shutt K, et al.
Antimicrob Agents Chemother
. 2010 Dec;
55(2):495-501.
PMID: 21135189
Ampicillin-sulbactam is commonly used as an empirical therapy for invasive infections where Escherichia coli is a potential pathogen. We evaluated the clinical and microbiologic characteristics of bloodstream infection due to...
9.
Qureshi Z, Paterson D, Pakstis D, Adams-Haduch J, Sandkovsky G, Sordillo E, et al.
Int J Antimicrob Agents
. 2010 Nov;
37(1):26-32.
PMID: 21075605
Enterobacter cloacae is a major nosocomial pathogen that causes serious infections, including bloodstream infections (BSIs). The clinical significance of extended-spectrum β-lactamase (ESBL) production in E. cloacae is not well established....
10.
Rebuilding the health care system in Afghanistan: an overview of primary care and emergency services
Acerra J, Iskyan K, Qureshi Z, Sharma R
Int J Emerg Med
. 2010 Feb;
2(2):77-82.
PMID: 20157448
Developing nations have many challenges to the growth of emergency medical systems. This development in Afghanistan is also complicated by many factors that plague post-conflict countries including an unstable political...